Crypto
Insider Hints Point to a MASSIVE Blockchain & RWA Tokenization Play — Oxbridge Re to 20x
Oxbridge Re subsidiary SurancePlus is quietly building a massive RWA tokenization and blockchain play, with the hints coming thick and fast, including key partnerships (Coinbase, Ripple, Zoniqx) and a $5M raise. What’s more, despite trading at around a $30 million market cap, SurancePlus is raising at a $60M valuation, hinting at a massive re-rating opportunity as the market catches on.
![Nasdaq darling Oxbridge Re [OXBR] gearing up for major blockchain & RWA tokenization push.](https://born2invest.com/wp-content/uploads/2025/02/pascal-bernardon-zt0HWquGXlQ-unsplash.jpg)
There’s no doubt about it by now — 2025’s shaping up to be the year of the RWA.
From Vlad Tenev’s recent doubling down on his RWA bombshell from last year, to BlackRock’s $10 trillion RWA tokenization play, there’s more momentum gathering here than a speeding freight train.
And that means one thing.
If you know where to look, juicy opportunities are coming in fast.
So where do you look to find these opportunities?
Well, there are a thousand and one places you can look.
Let me give you an example of how I found one such opportunity that I’m convinced could 20x this year — Oxbridge Re [NASDAQ: OXBR] and its SurancePlus subsidiary.
Here’s How I know Oxbridge Re’s SurancePlus Subsidiary Is Up to Something Huge
Being the casual nerd that I am, I like to read SEC filings for breakfast.
True story.
That’s how I stumbled across this little gem from Oxbridge Re [NASDAQ: OXBR].
Now, on the face of it, this filing’s all kinda meaningless.
It’s also incredibly dry and boring, as most SEC filings generally are.
But to give you the gist of it, it’s announcing a $5 million offering by SP Holdings (Oxbridge’s SurancePlus subsidiary). The proceeds of which are intended to drive “growth of SP Holdings’ Web-3 segment and for related activities in accordance with its business strategy.”
Now, there are two key elements to pay attention to here — the bit about “Web-3 segment” growth, and “activities in accordance with its business strategy.”
Why?
Because, if you’ve been following Oxbridge Re/SurancePlus, then you’d know that the whole “business strategy”/”Web-3” thing means just one thing — RWA tokenization.
Now, if you’re late to the party and want to get a good idea of what SurancePlus is all about, here’s an article to get you up to speed on the whole SurancePlus RWA tokenization story.
For the rest of you, there are two basic elements you need to know.
- SurancePlus is a subsidiary of Oxbridge Re, a Nasdaq-listed reinsurance provider.
- SurancePlus was created to issue tokenized reinsurance securities (RWA tokenization).
- To date, SurancePlus has successfully issued millions of dollars worth of tokenized reinsurance securities.
So now we have the basics, that leads us to the next question.
What does SurancePlus want to raise $5 million dollars for?
To state the obvious, we can probably safely assume that SurancePlus is gearing up for a major RWA tokenization push.
But that still doesn’t tell us what exactly they’re planning.
The Plot Thickens
The next piece of the puzzle comes in the form of an investor presentation I dug up on Oxbridge Re’s website.
If you clicked through to the presentation, turn to page 4. Otherwise, here’s the first bit you need — a SurancePlus organigram.
Now, if you’re already familiar with the company to date, the left-hand side of the chart should be no mystery to you.
For a couple of years now, SurancePlus has been issuing tokenized reinsurance contracts (which have been a huge hit with early RWA investors). And in this arrangement, Oxbridge Re is the licensed reinsurance provider, and SurancePlus is the token issuer.
But what’s this DSN Blockchain Technologies entity doing?
Well, here’s a hint.
This presentation was published on Feb 8, 2025, just a few weeks after the above SEC filing.
And in it, we also learn that DSN recently applied for Virtual Asset Service Provider (VASP) registration.
Now, taken alone, that’s still quite vague. A VASP could be anything from a cryptocurrency exchange to a digital assets hedge fund. But we can at least derive that SurancePlus is looking to turn DSN into some sort of “platform” for purchasing/managing digital assets.
So let’s dig a little bit deeper.
At the end of last week, Oxbridge also dropped this press release announcing they’d partnered with Coinbase [NASDAQ: COIN] Prime to build out their “ability to securely manage digital assets.” We also see a bit of language in that PR from Oxbridge’s CEO, Jay Madhu, hinting at things about integrating “cutting-edge blockchain solutions into our financial framework.”
So let’s put all of what we’ve got so far into one place.
- SurancePlus, an Oxbridge Re subsidiary, is raising $5 million via a private placement.
- SurancePlus’s DSN Blockchain Technologies arm has applied for VASP registration.
- Oxbridge Re is announcing a Coinbase [NASDAQ: COIN] partnership “to securely manage digital assets.”
And now for one final element that’s not exactly new (this happened last year) that we haven’t introduced here yet.
- SurancePlus has already partnered with Zoniqx/Ripple to provide its tokenization tech stack.
- The two have been quite chummy over the last couple of months, appearing at multiple major blockchain conferences together (with another 25-30 more already scheduled for this year).
Do you see what’s happening here?
No?
Let me spell it out.
SurancePlus, which was just a humble (albeit hugely undervalued) issuer of tokenized reinsurance securities, is making a play to become a major RWA issuer, most likely across multiple asset classes.
Just think about it.
The Coinbase [NASDAQ: COIN] partnership, the VASP registration, the $5 million raise, the Zoniqx/XRP tech stack… it’s all a little overkill if all SurancePlus was intending to do was to keep on doing more of the same.
But it’s all perfectly proportionate with what you’d expect to see from a company gearing up to start managing/issuing RWA tokenization projects at serious scale.
So What’s This All Worth?
For now, I’m going to leave the whole RWA tokenization story out of this “what’s it worth” bit.
Instead, I’m just going to spell out the cold hard facts.
So let’s start with what we know.
- Right now, Oxbridge has a little over 6 million shares outstanding.
- The Form 8-K announcing the $5 million offering mentioned that “investors in the offering will be granted private placement warrants to purchase up to an aggregate of 625,000 ordinary shares of Company.”
- Assuming 1 warrant per share, which would be normal, that would give us a subscription price of $8.00 per ordinary share ($5 million/625k).
- Currently, the Oxbridge Re has about 6.85 million shares outstanding.
Now, let’s add everything up.
We have 625k newly-issued shares + 6.85M outstanding shares, giving us a total of about 7.5 million shares.
Now multiply that by $8.
And voila.
That would give you a $60 million valuation, which is huge.
Like seriously huge.
To put that into perspective, Oxbridge Re [NASDAQ: OXBR] is currently trading at around $4.50 a share.
So we’re almost talking double your money once more investors start digesting all of the above.
And that’s just the beginning. After all, you can guarantee that the guys sinking their hard-earned into the private placement are gonna be looking for a little more than whatever they can arbitrage off the back of their warrants.
And have you seen what’s happening in the RWA space right now?
So in reality, we’ve got a very good chance of seeing Oxbridge Re go well beyond $8 a share this year.
Hitting Hyperdrive
So we already know that Oxbridge Re’s SurancePlus is raising at a pre-money valuation not far off 2x its parent company’s current market cap.
Which is already kinda crazy.
But here’s where it gets even more crazy. I reached out to a few people to confirm some details about everything above and learned two things.
First, the SurancePlus raise is apparently oversubscribed (huge investor demand) and yes, they really are raising at a $60 million valuation.
And second, that someone else has been quietly raising at an even more absurd valuation.
That someone else is Securitize — a similar platform to what I suspect SurancePlus’s DSN play is all about.
For background, Securitize did $12 million in revenue and is raising money at a $1 billion valuation right now. Or at least, that’s what I gleaned from a few of my PE contacts who, naturally, asked to remain anonymous.
So what does this mean for Oxbridge Re/SurancePlus and the DSN play?
Well, let me put a couple of things out there.
SurancePlus’s last RWA tokenization offering, its EpsilonCat Re, saw it offer 1,000,000 participation shares at $10 a pop. That’s $10 million dollars worth.
And its first offering, the DeltaCat Re token, was a $5 million issuance.
That’s a combined $15 million.
Now remember this — Securitize is raising at a $1bn valuation off the back of $12 million in revenue.
So, does this mean SurancePlus’s DSN play is also worth a billion?
Well, maybe. Maybe not.
For that to happen, we’ll need to see a few things fall into place.
For starters, so far, DSN hasn’t actually been approved as a VASP (although, given the crypto-friendly administration that’s moved in, we’ve got no reason to doubt that will happen).
We’re also going to need to see SurancePlus spun out as its own entity before the public market really appreciates just how undervalued it is. For better or worse, as long as it’s tied to Oxbridge Re [NASDAQ: OXBR], it’s going to be carrying too much “boring old reinsurance company” stigma.
But that’s alright, because it means we can get in while it’s cheap.
And it’s doubly alright when you consider that Oxbridge Re’s already announced its intention to spin out SurancePlus.
Now, of course, none of this guarantees a $1 billion valuation.
But one thing’s for certain.
Hitting somewhere around half of that — that is, around a $500 million valuation — is well within the realm of realistic expectations.
And when that happens, that will represent anything from a 10x-20x increase over Oxbridge Re’s [NASDAQ: OXBR] current market cap.
__
(Featured image by Pascal Bernardon via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions, including with regards to potential earnings in the Empire Flippers affiliate program. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
![](https://born2invest.com/wp-content/uploads/2018/11/logo-slogan.png)
-
Biotech1 week ago
Benchling Report: AI and Automation Reshaping Biopharma R&D
-
Crypto1 day ago
Over $500 Million Lost in Memecoin Scams in 2024
-
Crypto2 weeks ago
Altcoin ETFs on the Rise: XRP, Dogecoin, Solana, and More Await SEC Approval
-
Impact Investing1 week ago
Equinor Reduces Renewable Energy Commitment, Returns to Oil